<a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/2176476/open_sms">Send a text</a>In this special Flashcast episode of the WTR Small-Cap podcast, Tim Gerdeman and WTR Healthcare analyst Robert Sassoon break down why more than 90% of biotech companies listed on a U.S. exchange choose NASDAQ over the NYSE.

Send a text In this special Flashcast episode of the WTR Small-Cap podcast, Tim Gerdeman and WTR Healthcare analyst Robert Sassoon break down why more than 90% of biotech companies listed on a U.S. exchange choose NASDAQ over the NYSE.

<a href="https://www.buzzsprout.com/twilio/text_messages/2176476/open_sms" rel="noopener noreferrer">Send a text</a>In this special Flashcast episode of the WTR Small-Cap podcast, Tim Gerdeman and WTR Healthcare analyst Robert Sassoon break down why more than 90% of biotech companies listed on a U.S. exchange choose NASDAQ over the NYSE.

The lure of the NASDAQ for Biotechs

WTR Small-Cap Spotlight is your weekly guide to uncovering hidden value in the world of small-cap stocks. Each episode features insightful interviews with C-level executives, industry thought leaders, and Water Tower’s expert analysts. Tune in for actionable investment ideas and in-depth discussions on under-the-radar opportunities that can make a big impact on your portfolio&nbsp;

Business

Investing

WTR Small-Cap Spotlight is your weekly guide to uncovering hidden value in the world of small-cap stocks. Each episode features insightful interviews with C-level executives, industry thought leaders, and Water Tower’s expert analysts. Tune in for actionable investment ideas and in-depth discussions on under-the-radar opportunities that can make a big impact on your portfolio 

Share The lure of the NASDAQ for Biotechs

Sign up to save your podcasts

The lure of the NASDAQ for Biotechs

The lure of the NASDAQ for Biotechs

More shows like WTR Small-Cap Spotlight

Freakonomics Radio

Motley Fool Money

Macro Voices

Chit Chat Stocks

MicroCapClub